{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:05:55Z","timestamp":1758758755586,"version":"3.44.0"},"reference-count":62,"publisher":"Jaypee Brothers Medical Publishing","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.59556\/japi.71.0393","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T04:41:56Z","timestamp":1758688916000},"page":"71-75","source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 Therapeutics Why Not Angiotensin Receptor Blockers (ARBs)?"],"prefix":"10.59556","volume":"71","author":[{"given":"Hariharan T","family":"S","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"issue":"(3):","key":"key20250924044153_B1","doi-asserted-by":"crossref","first-page":"457\u2013","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission.","volume":"63","author":"Xu","year":"2020;","journal-title":"Sci China Life Sci"},{"issue":"(3):","key":"key20250924044153_B2","doi-asserted-by":"crossref","first-page":"364\u2013","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.","volume":"63","author":"Liu","year":"2020;","journal-title":"Sci China Life Sci"},{"issue":"(1):","key":"key20250924044153_B3","doi-asserted-by":"crossref","first-page":"290.","DOI":"10.1186\/s13054-020-03015-0","article-title":"Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients.","volume":"24","author":"Wu","year":"2020;","journal-title":"Crit Care"},{"key":"key20250924044153_B4","doi-asserted-by":"crossref","first-page":"14\u2013","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.","volume":"76:","author":"Verdecchia","year":"2020;","journal-title":"Eur J Int Med"},{"issue":"(7):","key":"key20250924044153_B5","doi-asserted-by":"crossref","first-page":"247\u2013","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging.","volume":"2","author":"Benigni","year":"2010;","journal-title":"EMBO Mol Med"},{"key":"key20250924044153_B6","doi-asserted-by":"crossref","first-page":"70.","DOI":"10.1186\/s40560-020-00483-y","article-title":"Thromboembolic disease in COVID-19 patients: a brief narrative review.","volume":"8:","author":"Mondal","year":"2020;","journal-title":"J Intensive Care"},{"issue":"(6965):","key":"key20250924044153_B7","doi-asserted-by":"crossref","first-page":"450\u2013","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.","volume":"426","author":"Li","year":"2003;","journal-title":"Nature"},{"issue":"(5742):","key":"key20250924044153_B8","doi-asserted-by":"crossref","first-page":"1864\u2013","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.","volume":"309","author":"Li","year":"2005;","journal-title":"Science"},{"issue":"(4):","key":"key20250924044153_B9","doi-asserted-by":"crossref","first-page":"1216\u2013","DOI":"10.1016\/j.bbrc.2004.05.114","article-title":"Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor.","volume":"319","author":"Hofmann","year":"2004;","journal-title":"Biochem Biophys Res Commun"},{"key":"key20250924044153_B10","first-page":"E014.","article-title":"Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia.","volume":"43:","author":"Sun","year":"2020;","journal-title":"Chin J Tuberc Respir Dis"},{"key":"key20250924044153_B11","first-page":"1\u2013","article-title":"AT1R blockers as tentative treatment for SARS-CoV-2 infections\u2014commentary.","author":"Gurwitz","year":"2020;","journal-title":"Drug Dev Res"},{"issue":"(15):","key":"key20250924044153_B12","doi-asserted-by":"crossref","first-page":"870\u2013","DOI":"10.1093\/cid\/ciaa329","article-title":"Is there an association between COVID-19 mortality and the renin-angiotensin system? A call for epidemiologic investigations.","volume":"71","author":"Hanff","year":"2020;","journal-title":"Clin Infect Dis"},{"issue":"(34):","key":"key20250924044153_B13","doi-asserted-by":"crossref","first-page":"30113\u2013","DOI":"10.1074\/jbc.M505111200","article-title":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).","volume":"280","author":"Lambert","year":"2005;","journal-title":"J Biol Chem"},{"issue":"(24):","key":"key20250924044153_B14","doi-asserted-by":"crossref","first-page":"12658\u2013","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.","volume":"84","author":"Matsuyama","year":"2010;","journal-title":"J Virol"},{"issue":"(2):","key":"key20250924044153_B15","doi-asserted-by":"crossref","first-page":"185\u2013","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.","volume":"14","author":"Zou","year":"2020;","journal-title":"Front Med"},{"issue":"(2):","key":"key20250924044153_B16","doi-asserted-by":"crossref","first-page":"631\u2013","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.","volume":"203","author":"Hamming","year":"2004;","journal-title":"J Pathol"},{"issue":"(7047):","key":"key20250924044153_B17","doi-asserted-by":"crossref","first-page":"112\u2013","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure.","volume":"436","author":"Imai","year":"2005;","journal-title":"Nature"},{"key":"key20250924044153_B18","doi-asserted-by":"crossref","first-page":"104350.","DOI":"10.1016\/j.yexmp.2019.104350","article-title":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway.","volume":"113:","author":"Ye","year":"2020;","journal-title":"Exp Mol Pathol"},{"key":"key20250924044153_B19","doi-asserted-by":"crossref","first-page":"7027.","DOI":"10.1038\/srep07027","article-title":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury.","volume":"4:","author":"Yang","year":"2014;","journal-title":"Sci Rep"},{"key":"key20250924044153_B20","doi-asserted-by":"crossref","first-page":"875\u2013","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.","volume":"11:","author":"Kuba","year":"2005;","journal-title":"Nat Med"},{"issue":"(3):","key":"key20250924044153_B21","doi-asserted-by":"crossref","first-page":"228\u2013","DOI":"10.1002\/path.5471","article-title":"Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).","volume":"251","author":"Bourgonje","year":"2020;","journal-title":"J Pathol"},{"issue":"(15):","key":"key20250924044153_B22","doi-asserted-by":"crossref","first-page":"2006\u2013","DOI":"10.1007\/s00018-007-6228-6","article-title":"Angiotensin-converting enzyme 2 in acute respiratory distress syndrome.","volume":"64","author":"Imai","year":"2007;","journal-title":"Cell Mol Life Sci"},{"issue":"(12):","key":"key20250924044153_B23","doi-asserted-by":"crossref","first-page":"1201\u2013","DOI":"10.1016\/S2213-2600(20)30370-2","article-title":"Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study.","volume":"8","author":"Grasselli","year":"2020;","journal-title":"Lancet Respir Med"},{"issue":"(12):","key":"key20250924044153_B24","doi-asserted-by":"crossref","first-page":"1671\u2013","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19.","volume":"126","author":"Zhang","year":"2020;","journal-title":"Circ Res"},{"key":"key20250924044153_B25","article-title":"Anti-hypertensive angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients.","author":"Liu","journal-title":"PAHO (WHO)"},{"issue":"(1):","key":"key20250924044153_B26","doi-asserted-by":"crossref","first-page":"757\u2013","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.","volume":"9","author":"Meng","year":"2020;","journal-title":"Emerg Microbes Infect"},{"issue":"(6):","key":"key20250924044153_B27","doi-asserted-by":"crossref","first-page":"1222\u2013","DOI":"10.1016\/j.mayocp.2020.03.026","article-title":"Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019.","volume":"95","author":"Sanchis-Gomar","year":"2020;","journal-title":"Mayo Clin Proc"},{"key":"key20250924044153_B28","article-title":"Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial. Preliminary report.","author":"Duarte","year":"2020.","journal-title":"medRxiv"},{"issue":"(17):","key":"key20250924044153_B29","doi-asserted-by":"crossref","first-page":"1653\u2013","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19.","volume":"382","author":"Vaduganathan","year":"2020;","journal-title":"N Engl J Med"},{"key":"key20250924044153_B30","article-title":"COVID-19 and hypertension: what we know and don\u2019t know.","author":"Kanwal","year":"2020.","journal-title":"Am Coll Cardiol"},{"key":"key20250924044153_B31","article-title":"COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers: Scientific brief, 7 May 2020.","author":"World Health Organization."},{"issue":"(3):","key":"key20250924044153_B32","doi-asserted-by":"crossref","first-page":"268\u2013","DOI":"10.1016\/j.jacc.2020.05.040","article-title":"Ramipril in high-risk patients with COVID-19.","volume":"76","author":"Amat-Santos","year":"2020;","journal-title":"J Am Coll Cardiol"},{"issue":"(1):","key":"key20250924044153_B33","doi-asserted-by":"crossref","first-page":"51\u2013","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects of angiotensin II receptor blockers and ACE (angiotensin-converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: a single-center retrospective study.","volume":"76","author":"Yang","year":"2020;","journal-title":"Hypertension"},{"issue":"(7):","key":"key20250924044153_B34","doi-asserted-by":"crossref","first-page":"825\u2013","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China.","volume":"5","author":"Li","year":"2020;","journal-title":"JAMA Cardiol"},{"issue":"(2):","key":"key20250924044153_B35","doi-asserted-by":"crossref","first-page":"168\u2013","DOI":"10.1001\/jama.2020.11301","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality.","volume":"324","author":"Fosbol","year":"2020;","journal-title":"JAMA"},{"issue":"(25):","key":"key20250924044153_B36","doi-asserted-by":"crossref","first-page":"2431\u2013","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19.","volume":"382","author":"Mancia","year":"2020;","journal-title":"N Engl J Med"},{"issue":"(10238):","key":"key20250924044153_B37","doi-asserted-by":"crossref","first-page":"1705\u2013","DOI":"10.1016\/S0140-6736(20)31030-8","article-title":"Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.","volume":"395","author":"de Abajo","year":"2020:","journal-title":"Lancet"},{"key":"key20250924044153_B38","doi-asserted-by":"crossref","first-page":"e2021004.","DOI":"10.4178\/epih.e2021004","article-title":"Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study.","volume":"43:","author":"Kim","year":"2021;","journal-title":"Epidemiol Health"},{"issue":"(2):","key":"key20250924044153_B39","doi-asserted-by":"crossref","first-page":"177\u2013","DOI":"10.1001\/jama.2020.11401","article-title":"Renin-angiotensin-aldosterone inhibitors and susceptibility to and severity of COVID-19.","volume":"324","author":"Curfman","year":"2020;","journal-title":"JAMA"},{"issue":"(20):","key":"key20250924044153_B40","doi-asserted-by":"crossref","first-page":"2605\u2013","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.","volume":"111","author":"Ferrario","year":"2005;","journal-title":"Circulation"},{"issue":"(5):","key":"key20250924044153_B41","doi-asserted-by":"crossref","first-page":"970\u2013","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.","volume":"43","author":"Ishiyama","year":"2004;","journal-title":"Hypertension"},{"issue":"(4):","key":"key20250924044153_B42","doi-asserted-by":"crossref","first-page":"H1351\u2013","DOI":"10.1152\/ajpheart.01186.2004","article-title":"Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure.","volume":"289","author":"Karram","year":"2005;","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"(6):","key":"key20250924044153_B43","doi-asserted-by":"crossref","first-page":"1382\u2013","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","article-title":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers.","volume":"75","author":"Danser","year":"2020;","journal-title":"Hypertension"},{"key":"key20250924044153_B44","doi-asserted-by":"crossref","first-page":"105996.","DOI":"10.1016\/j.rmed.2020.105996","article-title":"Severe respiratory SARS-CoV2 infection: does ACE2 receptor matter?","volume":"168:","author":"Perrotta","year":"2020;","journal-title":"Respir Med"},{"issue":"(6):","key":"key20250924044153_B45","doi-asserted-by":"crossref","first-page":"e50\u2013","DOI":"10.1016\/S2213-2600(20)30224-1","article-title":"SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors.","volume":"8","author":"Milne","year":"2020;","journal-title":"Lancet Respir Med"},{"issue":"(1):","key":"key20250924044153_B46","doi-asserted-by":"crossref","first-page":"15\u2013","DOI":"10.1093\/ajh\/hpu086","article-title":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker.","volume":"28","author":"Furuhashi","year":"2015;","journal-title":"Am J Hypertens"},{"issue":"(6):","key":"key20250924044153_B47","doi-asserted-by":"crossref","first-page":"567\u2013","DOI":"10.1111\/j.1440-1797.2011.01467.x","article-title":"Urinary angiotensin-converting enzyme 2 in patients with CKD.","volume":"16","author":"Mizuiri","year":"2011;","journal-title":"Nephrology (Carlton)"},{"issue":"(2):","key":"key20250924044153_B48","doi-asserted-by":"crossref","first-page":"101\u2013","DOI":"10.1159\/000368486","article-title":"Urinary angiotensin converting enzyme 2 increases in patients with type 2 diabetic mellitus.","volume":"40","author":"Liang","year":"2015;","journal-title":"Kidney Blood Press Res"},{"issue":"(9):","key":"key20250924044153_B49","doi-asserted-by":"crossref","first-page":"750\u2013","DOI":"10.1016\/j.jacc.2008.02.088","article-title":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system.","volume":"52","author":"Epelman","year":"2008;","journal-title":"J Am Coll Cardiol"},{"issue":"(2):","key":"key20250924044153_B50","doi-asserted-by":"crossref","first-page":"375\u2013","DOI":"10.1097\/HJH.0b013e32834f04b6","article-title":"Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications.","volume":"30","author":"Soro-Paavonen","year":"2012;","journal-title":"J Hypertens"},{"issue":"(8):","key":"key20250924044153_B51","first-page":"1280\u2013","article-title":"Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling.","volume":"19","author":"Walters","year":"2017;","journal-title":"Europace"},{"issue":"(4):","key":"key20250924044153_B52","doi-asserted-by":"crossref","first-page":"e61695.","DOI":"10.1371\/journal.pone.0061695","article-title":"Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study.","volume":"8","author":"Ortiz-P\u00e9rez","year":"2013;","journal-title":"PLoS One"},{"issue":"(4):","key":"key20250924044153_B53","doi-asserted-by":"crossref","first-page":"1470320316668435.","DOI":"10.1177\/1470320316668435","article-title":"Circulating ACE2 activity correlates with cardiovascular disease development.","volume":"17","author":"\u00dari","year":"2016;","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"(4):","key":"key20250924044153_B54","doi-asserted-by":"crossref","first-page":"618\u2013","DOI":"10.1002\/path.2987","article-title":"Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist.","volume":"225","author":"W\u00f6sten-van Asperen","year":"2011;","journal-title":"J Pathol"},{"issue":"(4):","key":"key20250924044153_B55","doi-asserted-by":"crossref","first-page":"395\u2013","DOI":"10.1097\/SHK.0000000000000302","article-title":"Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation.","volume":"43","author":"Li","year":"2015;","journal-title":"Shock"},{"issue":"(1):","key":"key20250924044153_B56","doi-asserted-by":"crossref","first-page":"100\u2013","DOI":"10.1016\/j.taap.2010.02.009","article-title":"Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2.","volume":"245","author":"Han","year":"2010;","journal-title":"Toxicol Appl Pharmacol"},{"issue":"(5):","key":"key20250924044153_B57","doi-asserted-by":"crossref","first-page":"631\u2013","DOI":"10.1113\/expphysiol.2007.041855","article-title":"Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.","volume":"93","author":"Hamming","year":"2008;","journal-title":"Exp Physiol"},{"issue":"(4):","key":"key20250924044153_B58","doi-asserted-by":"crossref","first-page":"269\u2013","DOI":"10.1042\/CS20090318","article-title":"Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition.","volume":"118","author":"Velkoska","year":"2010;","journal-title":"Clin Sci (Lond)"},{"issue":"(4):","key":"key20250924044153_B59","doi-asserted-by":"crossref","first-page":"477\u2013","DOI":"10.1113\/expphysiol.2011.063156","article-title":"Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.","volume":"97","author":"Burrell","year":"2012;","journal-title":"Exp Physiol"},{"issue":"(11):","key":"key20250924044153_B60","doi-asserted-by":"crossref","first-page":"649\u2013","DOI":"10.1042\/CS20120162","article-title":"Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.","volume":"123","author":"Burchill","year":"2012;","journal-title":"Clin Sci (Lond)"},{"key":"key20250924044153_B61","doi-asserted-by":"crossref","first-page":"90\u2013","DOI":"10.1016\/j.bcp.2017.07.022","article-title":"Azilsartan ameliorates diabetic cardiomyopathy in young db\/db mice through the modulation of ACE-2\/ANG 1-7\/Mas receptor cascade.","volume":"144:","author":"Sukumaran","year":"2017;","journal-title":"Biochem Pharmacol"},{"issue":"(18):","key":"key20250924044153_B62","first-page":"e00940\u2013","article-title":"Broad and differential animal angiotensin-converting enzyme 2 receptor usage by SARS-CoV-2.","volume":"94","author":"Zhao","year":"2020;","journal-title":"J Virol"}],"container-title":["Journal of the Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T04:42:04Z","timestamp":1758688924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-71-11-71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.59556\/japi.71.0393"],"URL":"https:\/\/doi.org\/10.59556\/japi.71.0393","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}